Consensus EPS · Q2 2026
$1.82
Consensus revenue · Q2 2026
$2.4B
Analysts
9
Expected report
Jul 30, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 9 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $2.3B | $2.4B | $2.5B |
| EPS | $1.70 | $1.82 | $1.91 |
| EBITDA | $393.3M | $414.3M | $428.3M |
| EBIT | $273.3M | $287.9M | $297.6M |
| Net income | $197.5M | $209.1M | $216.1M |
- Revenue$2.4B
- EPS$1.82
- EBITDA$414.3M
- EBIT$287.9M
- Net income$209.1M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $2.2B | $2.2B | +0.2% | $1.09 | $1.06 | +2.5% |
- Q1 2026+0.2%+2.5%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
| Metric | Now | 30d ago | 60d ago | 90d ago | 30d Δ |
|---|---|---|---|---|---|
| Revenue | $2.4B | $2.4B | — | — | -0.3% |
| EPS | $1.82 | $1.81 | — | — | +0.7% |
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Eastman Chemical (EMN) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 2 analysts.
- Low
- $70.00
- Consensus
- $79.56
- Median
- $80.00
- High
- $88.00
- Current
- $69.38
- Upside
- +14.7%
Upside calculated vs most recent trading price of $69.38.
Analyst ratings
Consensus: Buy — based on 35 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 2, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Jun 24, 2026 | Citigroup | maintain | Buy | Buy |
| May 5, 2026 | RBC Capital | maintain | Sector Perform | Sector Perform |
| May 5, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| May 4, 2026 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| May 4, 2026 | JP Morgan | maintain | Overweight | Overweight |
| May 4, 2026 | Citigroup | maintain | Buy | Buy |
| Apr 16, 2026 | Citigroup | maintain | Buy | Buy |
| Apr 14, 2026 | JP Morgan | upgrade | Neutral | Overweight |
| Apr 9, 2026 | UBS | maintain | Buy | Buy |
- Jul 2, 2026Morgan StanleyOverweight
- Jun 24, 2026CitigroupBuy
- May 5, 2026RBC CapitalSector Perform
- May 5, 2026Morgan StanleyOverweight
- May 4, 2026Wells FargoEqual Weight
- May 4, 2026JP MorganOverweight
- May 4, 2026CitigroupBuy
- Apr 16, 2026CitigroupBuy
- Apr 14, 2026JP MorganOverweight
- Apr 9, 2026UBSBuy
Frequently asked questions
Eastman Chemical (EMN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.15% TTM
- Dividend Profile4.83% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History1 split
How this company returns cash to shareholders — buybacks, dividends, and stock splits.